The efficacy of ruxolitinib cream in pediatric patients shows that nonsteroidal management of atopic dermatitis is feasible, ...

Eli Lilly and Almirall’s Ebglyss (lebrikizumab) has been shown to significantly improve the signs and symptoms of atopic ...

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of atopic comorbidities that they had, according to data published in Annals of ...

The International Medical Derm Summit 2025 highlighted China's dermatological advancements, fostering global collaboration ...

Children/adolescents with atopic dermatitis and a sleep disorder faced a greater risk for ADHD, anxiety, depression and ...

The use of dupilumab for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents. The association between dupilumab and psoriasis ...

About 10 percent of people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. Here are the most important things to know if you have it.

Without adequate treatment, atopic dermatitis can get worse, leading to other health problems -- both now and in the future. Scratching can lead to skin infections, for instance, and nighttime ...

One in 10 people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. These quick facts can help you manage it.

Novel research has revealed that adolescent vaping of current delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and synthetic cannabinoids (SCs) has increased between 2021 and 2023. Also ...

Evidence-based recommendations on nemolizumab (Nemluvio) for treating moderate to severe atopic dermatitis in people 12 years and over ...